Efficacy and safety of BRAF inhibitors (BRAFi) +/- MEK...

  • Main
  • 2019 / 4
  • Efficacy and safety of BRAF inhibitors (BRAFi) +/- MEK...

Efficacy and safety of BRAF inhibitors (BRAFi) +/- MEK inhibitors (MEKi) in BRAF mutant (BRAFm) advanced non-small cell lung cancer (NSCLC): findings from the real-life cohort

Dudnik, Elizabeth, Bar, Jair, Peled, Nir, Bshara, Elias, Kuznetsov, Teodor, Cohen, Aharon Yonathan, Shochat, Tzippy, Nechushtan, Hovav, Onn, Amir, Agbarya, Abed, Moskovitz, Mor, Keren, Shoshana, Popov
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lung Cancer
DOI:
10.1016/j.cllc.2019.03.007
Date:
April, 2019
File:
PDF, 1.09 MB
english, 2019
Conversion to is in progress
Conversion to is failed